181 related articles for article (PubMed ID: 21832846)
1. Choosing not to take phosphate binders: the role of dialysis patients' medication beliefs.
Wileman V; Chilcot J; Norton S; Hughes L; Wellsted D; Farrington K
Nephron Clin Pract; 2011; 119(3):c205-13. PubMed ID: 21832846
[TBL] [Abstract][Full Text] [Related]
2. Medication beliefs are associated with phosphate binder non-adherence in hyperphosphatemic haemodialysis patients.
Wileman V; Farrington K; Wellsted D; Almond M; Davenport A; Chilcot J
Br J Health Psychol; 2015 Sep; 20(3):563-78. PubMed ID: 25209368
[TBL] [Abstract][Full Text] [Related]
3. Phosphate binders usage, patients knowledge, and adherence. A cross-sectional study in 4 centers at Qassim, Saudi Arabia.
Aleidi AM; Alayed NJ; Alduraibi HM; Alqassimi NS; Ismail AA
Saudi Med J; 2020 Oct; 41(10):1076-1082. PubMed ID: 33026048
[TBL] [Abstract][Full Text] [Related]
4. Interventional study to improve adherence to phosphate binder treatment in dialysis patients.
Hjemås BJ; Bøvre K; Mathiesen L; Lindstrøm JC; Bjerknes K
BMC Nephrol; 2019 May; 20(1):178. PubMed ID: 31101020
[TBL] [Abstract][Full Text] [Related]
5. Implementation and effectiveness of an intensive education program on phosphate control among hemodialysis patients: a non-randomized, single-arm, single-center trial.
Yin J; Yin J; Lian R; Li P; Zheng J
BMC Nephrol; 2021 Jul; 22(1):243. PubMed ID: 34210293
[TBL] [Abstract][Full Text] [Related]
6. The economic impact of improving phosphate binder therapy adherence and attainment of guideline phosphorus goals in hemodialysis patients: a Medicare cost-offset model.
Ramakrishnan K; Braunhofer P; Newsome B; Lubeck D; Wang S; Deuson J; Claxton AJ
Adv Ther; 2014 Dec; 31(12):1272-86. PubMed ID: 25479935
[TBL] [Abstract][Full Text] [Related]
7. The impact of nurse-led education on haemodialysis patients' phosphate binder medication adherence.
Sandlin K; Bennett PN; Ockerby C; Corradini AM
J Ren Care; 2013 Mar; 39(1):12-8. PubMed ID: 23432740
[TBL] [Abstract][Full Text] [Related]
8. Adherence to phosphate binders in hemodialysis patients: prevalence and determinants.
Van Camp YP; Vrijens B; Abraham I; Van Rompaey B; Elseviers MM
J Nephrol; 2014 Dec; 27(6):673-9. PubMed ID: 24563270
[TBL] [Abstract][Full Text] [Related]
9. Dietitian-led education program to improve phosphate control in a single-center hemodialysis population.
Reddy V; Symes F; Sethi N; Scally AJ; Scott J; Mumtaz R; Stoves J
J Ren Nutr; 2009 Jul; 19(4):314-20. PubMed ID: 19539185
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of educational interventions with dialysis patient].
Parmier M; Gourieux B; Krummel T; Bazin-Kara D; Dory A; Hannedouche T
Nephrol Ther; 2016 Dec; 12(7):516-524. PubMed ID: 27776970
[TBL] [Abstract][Full Text] [Related]
11. Self-Motivation Is Associated With Phosphorus Control in End-Stage Renal Disease.
Umeukeje EM; Merighi JR; Browne T; Victoroff JN; Umanath K; Lewis JB; Ikizler TA; Wallston KA; Cavanaugh K
J Ren Nutr; 2015 Sep; 25(5):433-9. PubMed ID: 25912398
[TBL] [Abstract][Full Text] [Related]
12. Phosphate balance in ESRD: diet, dialysis and binders against the low evident masked pool.
Galassi A; Cupisti A; Santoro A; Cozzolino M
J Nephrol; 2015 Aug; 28(4):415-29. PubMed ID: 25245472
[TBL] [Abstract][Full Text] [Related]
13. Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis.
Jamal SA; Vandermeer B; Raggi P; Mendelssohn DC; Chatterley T; Dorgan M; Lok CE; Fitchett D; Tsuyuki RT
Lancet; 2013 Oct; 382(9900):1268-77. PubMed ID: 23870817
[TBL] [Abstract][Full Text] [Related]
14. Improvement of therapeutic compliance in haemodialysis patients with poor phosphorus control and adherence to treatment with binders: COMQUELFOS study.
Dolores Arenas M; Pérez-García R; Bennouna M; Blanco A; Mauricio O; Prados MD; Lerma JL; Luisa Muñiz M; Belén Martín M;
Nefrologia; 2013; 33(2):196-203. PubMed ID: 23364580
[TBL] [Abstract][Full Text] [Related]
15. Use of phosphate binders in chronic kidney disease.
Ketteler M; Biggar PH
Curr Opin Nephrol Hypertens; 2013 Jul; 22(4):413-20. PubMed ID: 23736841
[TBL] [Abstract][Full Text] [Related]
16. Intensive Hemodialysis, Mineral and Bone Disorder, and Phosphate Binder Use.
Copland M; Komenda P; Weinhandl ED; McCullough PA; Morfin JA
Am J Kidney Dis; 2016 Nov; 68(5S1):S24-S32. PubMed ID: 27772640
[TBL] [Abstract][Full Text] [Related]
17. Multidisciplinary education approach to optimize phosphate control among hemodialysis patients.
Chan MW; Cheah HM; Mohd Padzil MB
Int J Clin Pharm; 2019 Oct; 41(5):1282-1289. PubMed ID: 31302884
[TBL] [Abstract][Full Text] [Related]
18. Effect of gastric acid suppression with pantoprazole on the efficacy of calcium carbonate as a phosphate binder in haemodialysis patients.
Cervelli MJ; Shaman A; Meade A; Carroll R; McDonald SP
Nephrology (Carlton); 2012 Jul; 17(5):458-65. PubMed ID: 22471559
[TBL] [Abstract][Full Text] [Related]
19. [Use of the aluminum phosphate-binders in hemodialysis in the ultrapure water era].
Arenas MD; Malek T; Gil MT; Moledous A; Núñez C; Alvarez-Ude F
Nefrologia; 2008; 28(2):168-73. PubMed ID: 18454706
[TBL] [Abstract][Full Text] [Related]
20. Profiling patient attitudes to phosphate binding medication: a route to personalising treatment and adherence support.
Chater AM; Parham R; Riley S; Hutchison AJ; Horne R
Psychol Health; 2014; 29(12):1407-20. PubMed ID: 25012529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
